Publications de la cohorte


Barger D, Leleux O, Conte V, Sapparrart V, Gapillout M, Crespel I, Erramouspe M, Delveaux S, Dabis F, Bonnet F

Integrating Electronic Patient-Reported Outcome Measures into Routine HIV Care and the ANRS CO3 Aquitaine Cohort's Data Capture and Visualization System (QuAliV): Protocol for a Formative Research Study.

JMIR Res Protoc. 2018 Jun 7;7(6):e147.


Duffau P, Ozanne A, Bonnet F, Lazaro E, Cazanave C, Blanco P, Rivière E, Desclaux A, Hyernard C, Gensous N, Pellegrin I, Wittkop L

Multimorbidity, age-related comorbidities and mortality: association of activation, senescence and inflammation markers in HIV adults.

AIDS. 2018 Jul 31;32(12):1651-1660.


Collaborations nationales ou internationales


Achhra AC, Sabin C, Ryom L, Hatleberg C, Antonella dʼAminio M, de Wit S, Phillips A, Pradier C, Weber R, Reiss P, El-Sadr W, Bonnet F, Mocroft A, Lundgren J, Law MG; D:A:D Study Group

Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals: D: A: D Cohort Analysis. J Acquir Immune Defic Syndr.

2018 Aug 15;78(5):579-588.


AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord

Non-Hodgkin lymphoma risk in adults living with HIV across five continents.

AIDS. 2018 Nov 28;32(18):2777-2786.


Caniglia EC, Phillips A, Porter K, Sabin CA, Winston A, Logan R, Gill J, Vandenhende MA, Barger D, Lodi S, Moreno S, Arribas JR, Pacheco A, Cardoso SW, Chrysos G, Gogos C, Abgrall S, Costagliola D, Meyer L, Seng R, van Sighem A, Reiss P, Muga R, Hoyos SP, Braun D, Hauser C, Barrufet P, Leyes M, Tate J, Justice A, Hernán MA

Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological Conditions. J Acquir Immune Defic Syndr.

2018 Jan 1;77(1):102-109.


Hatleberg CI, Ryom L, El-Sadr W, Mocroft A, Reiss P, De Wit S, Dabis F, Pradier C, d’Arminio Monforte A, Kovari H, Law M, Lundgren JD, Sabin CA; Data Collection of Adverse Events of Anti-HIV drugs (D:A:D) Study group

Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study.

J Int AIDS Soc. 2018 Mar;21(3):e25083.


Hatleberg CI, Ryom L, d’Arminio Monforte A, Fontas E, Reiss P, Kirk O, El-Sadr W, Phillips A, de Wit S, Dabis F, Weber R, Law M, Lundgren JD, Sabin C; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group

Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

HIV Med. 2018 Oct;19(9):605-618.


IeDEA and COHERE Cohort Collaborations

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs.

Clin Infect Dis. 2018 Mar 5;66(6):893-903.


Pettit AC, Giganti MJ, Ingle SM, May MT, Shepherd BE, Gill MJ, Fätkenheuer G, Abgrall S, Saag MS, Del Amo J, Justice AC, Miro JM, Cavasinni M, Dabis F, Monforte AD, Reiss P, Guest J, Moore D, Shepherd L, Obel N, Crane HM, Smith C, Teira R, Zangerle R, Sterne JA, Sterling TR; Antiretroviral Therapy Cohort Collaboration (ART-CC) investigators

Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation.

J Int AIDS Soc. 2018 Jan;21(1):e25031.


Ryom L, Lundgren JD, El-Sadr W, Reiss P, Kirk O, Law M, Phillips A, Weber R, Fontas E, d’ Arminio Monforte A, De Wit S, Dabis F, Hatleberg CI, Sabin C, Mocroft A; D:A:D study group

Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.

Lancet HIV. 2018 Jun;5(6):e291-e300.


AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord

Non-Hodgkin lymphoma risk in adults living with HIV across five continents.

AIDS. 2018 Nov 28;32(18):2777-2786.


Ronit A, Hatleberg CI, Ryom L, Bonnet F, El-Sadr W, Reiss P, Weber R, Pradier C, De Wit S, Law M, d’Arminio Monforte A, Lundgren J, Mocroft A, Phillips AN, Sabin CA; D:A:D Study Group

Associations between serum albumin and serious non-AIDS events among people living with HIV.

AIDS. 2018 Aug 24;32(13):1837-1848.


Sabin CA, Ryom L, d’Arminio Monforte A, Hatleberg CI, Pradier C, El-Sadr W, Kirk O, Weber R, Phillips AN, Mocroft A, Bonnet F, Law M, de Wit S, Reiss P, Lundgren JD; D:A:D Study Group

Abacavir use and risk of recurrent myocardial infarction.

AIDS. 2018 Jan 2;32(1):79-88.